Towards in silico Process Modeling for Vaccines.

Journal: Trends in biotechnology
Published Date:

Abstract

Chemical, manufacturing, and control development timelines occupy a significant part of vaccine end-to-end development. In the on-going race for accelerating timelines, in silico process development constitutes a viable strategy that can be achieved through an artificial intelligence (AI)-driven or a mechanistically oriented approach. In this opinion, we focus on the mechanistic option and report on the modeling competencies required to achieve it. By inspecting the most frequent vaccine process units, we identify fluid mechanics, thermodynamics and transport phenomena, intracellular modeling, hybrid modeling and data science, and model-based design of experiments as the pillars for vaccine development. In addition, we craft a generic pathway for accommodating the modeling competencies into an in silico process development strategy.

Authors

  • Antonio Gaetano Cardillo
    Technical Research and Development, GSK, 1 Via Fiorentina, 53100 Siena, SI, Italy.
  • Maria Monica Castellanos
    Technical Research and Development, GSK, 14200 Shady Grove Rd, Rockville, MD 20850, USA.
  • Benoit Desailly
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium.
  • Sandrine Dessoy
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium.
  • Marco Mariti
    Technical Research and Development, GSK, 1 Via Fiorentina, 53100 Siena, SI, Italy.
  • Rui M C Portela
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium.
  • Bernadette Scutella
    Technical Research and Development, GSK, 14200 Shady Grove Rd, Rockville, MD 20850, USA.
  • Moritz von Stosch
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium; Current affiliation: Data How AG, Zürichstrasse 137, 8600 Dübendorf, Switzerland.
  • Emanuele Tomba
    Technical Research and Development, GSK, 1 Via Fiorentina, 53100 Siena, SI, Italy.
  • Christos Varsakelis
    Technical Research and Development, GSK, 89 Rue De L'Institut, B-1330 Rixensart, Belgium. Electronic address: cvarsake@its.jnj.com.